Vousden Karen H bought BMY
February 1, 2026 · Form 4 insider transaction
Vousden Karen H bought 3,996 shares of Bristol-Myers Squibb Company at $55.05 per share, a transaction worth $220.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,996
Price
$55.05
Total value
$220.0K
InsiderVousden Karen H
Role—
SecurityDeferred Share Units
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2026
Filing dateFebruary 3, 2026
Shares owned after41,069
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.; Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.